Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Short Interest Update

Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) saw a large decline in short interest in December. As of December 15th, there was short interest totalling 81,400 shares, a decline of 19.2% from the November 30th total of 100,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Newron Pharmaceuticals Price Performance

OTCMKTS:NWPHF remained flat at $9.36 on Tuesday. The firm’s fifty day moving average is $9.36 and its 200-day moving average is $9.92. Newron Pharmaceuticals has a 1 year low of $9.10 and a 1 year high of $12.00.

About Newron Pharmaceuticals

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.